AI assistant
Sending…
CONMED Corp — Director's Dealing 2014
Dec 12, 2014
31971_dirs_2014-12-12_05ada985-1cb0-4f9d-a387-dc3e3f80b6ce.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2014-12-12
Reporting Person: MANDIA STEPHEN (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-12-12 | Common Stock | M | 4500 | $32.58 | Acquired | 26899.5458 | Direct |
| 2014-12-12 | Common Stock | S | 4500 | $43.2256 | Disposed | 22399.5458 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-12-12 | Options To Purchase Common Stock | $32.58 | M | 4500 | Disposed | 2015-05-18 | Common Stock (4500) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.08 to $43.56. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
More from CONMED Corp
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7